What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Enzyme
Kenji Izuhara mainly investigates Immunology, Interleukin 13, Periostin, Asthma and Immunoglobulin E.
Immunology and Receptor are frequently intertwined in his study.
As part of the same scientific family, he usually focuses on Interleukin 13, concentrating on Fibronectin and intersecting with Homology modeling, Cytokine receptor, Mutant and Lamina reticularis.
His Periostin research integrates issues from Fibrosis, Pathology, Matricellular protein, Idiopathic pulmonary fibrosis and Biomarker.
Asthma is a subfield of Internal medicine that Kenji Izuhara explores.
His Immunoglobulin E study incorporates themes from STAT6, Alpha, Adoptive cell transfer and Antigen.
His most cited work include:
- Periostin: A novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals (495 citations)
- Genetic variants of IL-13 signalling and human asthma and atopy (420 citations)
- Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma. (338 citations)
What are the main themes of his work throughout his whole career to date?
Kenji Izuhara focuses on Immunology, Periostin, Asthma, Internal medicine and Biomarker.
Immunology is represented through his Interleukin 13, Pathogenesis, Inflammation, Immunoglobulin E and Allergy research.
Kenji Izuhara works mostly in the field of Interleukin 13, limiting it down to topics relating to Receptor and, in certain cases, Signal transduction.
His study explores the link between Periostin and topics such as Idiopathic pulmonary fibrosis that cross with problems in Pulmonary fibrosis.
His study in Asthma is interdisciplinary in nature, drawing from both Pulmonary function testing and Eosinophilic.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Endocrinology.
He most often published in these fields:
- Immunology (46.74%)
- Periostin (41.36%)
- Asthma (31.16%)
What were the highlights of his more recent work (between 2018-2021)?
- Periostin (41.36%)
- Internal medicine (19.26%)
- Immunology (46.74%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Periostin, Internal medicine, Immunology, Asthma and Biomarker.
His work carried out in the field of Periostin brings together such families of science as Cancer research, Matricellular protein and Pulmonary fibrosis, Lung, Idiopathic pulmonary fibrosis.
His Internal medicine research incorporates elements of Gastroenterology and Omalizumab.
As part of his studies on Immunology, he often connects relevant areas like Airway.
His Asthma study combines topics in areas such as Immunoglobulin E, Allergen, Eosinophilic and Nasal polyps.
His biological study spans a wide range of topics, including Stromal cell, Pathogenesis, Carcinogenesis, Atopic dermatitis and Interleukin 13.
Between 2018 and 2021, his most popular works were:
- EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma. (55 citations)
- Periostin: An emerging biomarker for allergic diseases. (22 citations)
- Dupilumab: Basic aspects and applications to allergic diseases. (16 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
Kenji Izuhara spends much of his time researching Immunology, Periostin, Asthma, Inflammation and Allergy.
His Immunology study frequently draws connections between adjacent fields such as Age related.
His Periostin research includes themes of Cancer research, Gastroenterology, Matricellular protein, Idiopathic pulmonary fibrosis and Biomarker.
His research integrates issues of Fibrosis and Lung in his study of Matricellular protein.
His Asthma study incorporates themes from Airway, MEDLINE, Bioinformatics and Nasal polyps.
His research investigates the link between Inflammation and topics such as Atopic dermatitis that cross with problems in Interleukin, Pathogenesis, Tumor necrosis factor alpha and Phenotype.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
